Insights

Innovative Detection Technology PathogenDx's proprietary Dynamic Dimensional Detection (D3 Array) technology allows for rapid, multiplexed pathogen detection in food, plants, and clinical samples. This advanced solution presents opportunities to partner with testing laboratories and industrial food producers looking for faster, more accurate testing methods to enhance safety and compliance.

Expanding Market Reach Recent launches such as the combined bacterial and fungal assays and detection of Salmonella and other serotypes demonstrate the company's focus on expanding its product portfolio. Business development efforts could target poultry producers, food safety labs, and agricultural suppliers seeking reliable pathogen testing solutions.

Recognition and Validation The company received the 2024 North American New Product Innovation Award from Frost & Sullivan, endorsing its innovative approach. Leveraging this industry recognition can facilitate outreach to potential clients and partners emphasizing cutting-edge technology and proven excellence.

Growth through Collaborations PathogenDx's recent advisory board addition and partnerships with poultry producers suggest openness to strategic collaborations. Engaging with industry experts, food safety organizations, and biotech innovators could enhance product development and expand distribution channels.

Funding and Market Position With $11 million in funding and a focus on developing advanced testing solutions, PathogenDx is positioned for growth within a market valued for rapid pathogen detection. Sales efforts can target food safety and clinical diagnostics sectors where speed, accuracy, and cost-efficiency are critical buying criteria.

Similar companies to PathogenDx

PathogenDx Tech Stack

PathogenDx uses 8 technology products and services including JSON-LD, Ensighten, Google Tag Manager, and more. Explore PathogenDx's tech stack below.

  • JSON-LD
    Javascript Frameworks
  • Ensighten
    Tag Management
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players
  • Contact Form 7
    Web Platform Extensions
  • Nginx
    Web Servers
  • Facebook
    Widgets
  • Google Plus
    Widgets

Media & News

PathogenDx's Email Address Formats

PathogenDx uses at least 1 format(s):
PathogenDx Email FormatsExamplePercentage
FLast@pathogendx.comJDoe@pathogendx.com
48%
First@pathogendx.comJohn@pathogendx.com
2%
FLast@pathogendx.comJDoe@pathogendx.com
48%
First@pathogendx.comJohn@pathogendx.com
2%

Frequently Asked Questions

Where is PathogenDx's headquarters located?

Minus sign iconPlus sign icon
PathogenDx's main headquarters is located at 9375 E. Shea Blvd. Suite 100, Scottsdale, AZ 85260, US. The company has employees across 1 continents, including North America.

What is PathogenDx's phone number?

Minus sign iconPlus sign icon
You can contact PathogenDx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PathogenDx's official website and social media links?

Minus sign iconPlus sign icon
PathogenDx's official website is pathogendx.com and has social profiles on LinkedInCrunchbase.

What is PathogenDx's SIC code NAICS code?

Minus sign iconPlus sign icon
PathogenDx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PathogenDx have currently?

Minus sign iconPlus sign icon
As of October 2025, PathogenDx has approximately 28 employees across 1 continents, including North America. Key team members include Vice President Of Product Development: B. K.Vice President Operations: W. R.Ceo And Co-Founder: M. P.. Explore PathogenDx's employee directory with LeadIQ.

What industry does PathogenDx belong to?

Minus sign iconPlus sign icon
PathogenDx operates in the Biotechnology Research industry.

What technology does PathogenDx use?

Minus sign iconPlus sign icon
PathogenDx's tech stack includes JSON-LDEnsightenGoogle Tag ManagerYouTubeContact Form 7NginxFacebookGoogle Plus.

What is PathogenDx's email format?

Minus sign iconPlus sign icon
PathogenDx's email format typically follows the pattern of FLast@pathogendx.com. Find more PathogenDx email formats with LeadIQ.

How much funding has PathogenDx raised to date?

Minus sign iconPlus sign icon
As of October 2025, PathogenDx has raised $11M in funding. The last funding round occurred on Sep 30, 2019 for $7.5M.
PathogenDx

PathogenDx

Biotechnology ResearchUnited States11-50 Employees

PathogenDx, Inc. (PDx) is a biotechnology company that develops testing kits, automation, and software to detect pathogens in plants, food, and the body. The company's patented multiplexed molecular testing technology, Dynamic Dimensional Detection (https://pathogendx.com/science/) or D3 Array™, can rapidly detect and identify up to 50 pathogens simultaneously, in a single well test, in less than a single shift providing triplicate data per target/analyte for confidence and certainty in results with a simple and easy process. Our technology is equipment agnostic, and our analytics is automated through our cloud-based software. Our mission is to provide testing technology and solutions for the clinical, food, and agricultural testing markets for Better and Health and safety.

Section iconCompany Overview

Headquarters
9375 E. Shea Blvd. Suite 100, Scottsdale, AZ 85260, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $11M

    PathogenDx has raised a total of $11M of funding over 2 rounds. Their latest funding round was raised on Sep 30, 2019 in the amount of $7.5Mas a Series B.

  • $10M$25M

    PathogenDx's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $11M

    PathogenDx has raised a total of $11M of funding over 2 rounds. Their latest funding round was raised on Sep 30, 2019 in the amount of $7.5Mas a Series B.

  • $10M$25M

    PathogenDx's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.